Approval of COVID19-study

 Maastricht University Hospital receives approvals to start study with Annexin Pharmaceuticals drug candidate, ANXV, in patients with COVID19.  STOCKHOLM, SWEDEN (January 19, 2022) – Annexin Pharmaceuticals AB ...
Back to top